Rabies is known as the most fatal disease in all warm-blooded animals, including dogs. Among animals that transmit rabies, dogs are mainly responsible for transmitting animal rabies in Asian countries. Detection of rabies virus (RABV) antibodies in dogs is performed by fluorescent antibody virus neutralization (FAVN) test or rapid fluorescent focus inhibition test. These standard assays are difficult to carry out in diagnostic laboratories without sufficient instruments, designated RABV, and cell culture systems. An alternative assay that is easy to conduct and time efficient is required for rapid sero-surveillance following vaccination. Recombinant baculovirus expressing RABV nucleoprotein (RVN) was constructed and the recombinant protein was purified using Ni-NTA and fast protein liquid column chromatography. We developed and evaluated an indirect enzyme-linked immunosorbent assay (I-ELISA) with recombinant RVN for the detection of RABV antibodies in 122 dog serum samples. The I-ELISA results obtained from these samples were compared with FAVN results. The sensitivity, specificity, and accuracy of I-ELISA were 88.1%, 92.5%, and 91.0%, respectively, compared with FAVN. Results of I-ELISA were significantly correlated with that of FAVN (r = 0.81). These results suggest that I-ELISA with recombinant RVN is useful for sero-surveillance of RABV in dog sera.
INTRODUCTION

Rabies is caused by rabies virus (RABV)
and only a small amount of serum is needed; additionally, the procedure is simple and safer than the FAVN test (6) . A few ELISA kits specific for the RABV antibody have been commercialized for animals, but the kits are expensive and limited to use at the right time due to production limitations (7, 8) . Therefore, an N protein-based ELISA was developed to test the quality of vaccines (9) .
In the present study, we expressed recombinant RVN protein in Sf9 cells derived from Spodoptera frugiperda and developed and evaluated the indirect ELISA (I-ELISA) method using purified recombinant RVN protein for the detection of RABV antibodies in dogs. 
MATERIALS AND METHODS
Cells
Fluorescent Assay Virus Neutralization (FAVN) test
The neutralizing antibody titers in the serum samples were determined using a FAVN test in 96-well cell culture plates. The test was conducted in accordance with the OIE methodology that was described in the manual of diagnostic test and vaccines for terrestrial animals of OIE. In brief, all serum samples were heat-inactivated at 56℃ for 30 min prior to the test. Serial three-fold dilutions of serum samples with final volume of 100 μl were made in duplicate well.
The CVS11 RABV strain at concentration of 100 FAID 50 / 50 μl was added to each well and the plates were placed for 1 h at 37℃. Next, 50 μl of a BHK-21 cell suspension (4 × 10 5 cells/ml) was added to each well, and the plates were incubated for 48 h at 37℃ in a humidified 0.5% CO 2 incubator. After incubation, the growth medium was discarded, the mono layers of BHK-21 cell was washed with phosphatebuffered saline (PBS) and was fixed in 80% cold acetone at -20℃ for 20 min. After dry for 1 h at room temperature, 
Statistical analysis
Linear regression analysis (least-squares method) was used to determine the correlation between I-ELISA data and FAVN data. The correlation coefficient (r value) was computed using Sigma Plot version 10.0 for Windows (Jandel;
San Rafael, CA, USA). A p-value < 0.05 was considered statistically significant.
RESULTS
Expression of recombinant RVN protein in Sf9 insect cells
The RVN gene was cloned into pGEM-T and sub-cloned into pBluBac4.5/V5-His vector, which encodes RVN gene with a six-histidine tag in the C-terminal region (Fig. 1) .
After transfection into Sf9 cells, the production of recombinant RVN baculovirus was confirmed by plaque assay followed by PCR assay against recombinant RVN baculovirus and was identified by the presence of cytopathic effect and fluorescent antibody staining with anti-6-his monoclonal antibody or specific monoclonal antibody against RVN protein (Fig. 2) .
Optimization of I-ELISA
Recombinant RVN protein was purified via two chromatographic steps and the purified protein was identified as a gel electrophoresis (SDS-PAGE) and Western blotting using a monoclonal antibody to the RVN protein (Fig. 3) . The optimal antigen concentration (1.0 μg/ml) and serum dilution Based on these results, the I-ELISA kit was prepared, and 122 dog serum samples were evaluated.
Determination of the RABV antibody titer
Two different antibody detection assays (FAVN and I-ELISA) were carried out on 122 dog serum samples to detect RABV antibodies. Table 2 
Application of I-ELISA to dog sera
The absorbance value from I-ELISA for the 122 serum samples was compared with titers determined by FAVN to as Escherichia coli (6, 11, 12) , insect cells (13) , yeast (14) , and plant (15) for use as an antigen of serological assays.
In this study, we established recombinant RVN protein expression system using recombinant baculovirus system. One of the most important factors affecting the sensitivity and specificity of ELISA is the use of highly purified antigen (16) . Considering the above, we used the recombinant RVN protein purified with Ni-NTA affinity chromatography and FPLC column as an antigen to increase the sensitivity and specificity of I-ELISA.
The sensitivity, specificity, and accuracy of the I-ELISA as well as their correlations with results obtained using FAVN test were determined using 122 dog serum samples.
The sensitivity of I-ELISA compared with FAVN (88.1%) was similar to that obtained from Inoue et al. (91.7%) who expressed it in Escherichia coli. However, the specificity (92.5%) was slightly lower than that (100%) of a previous study, indicating that improvement is needed (11) . Our results also showed that the absorbance result of the I-ELISA was significantly correlated with that of the FAVN titer (r = 0.81).
Moreover, the I-ELISA correlations are consistent with the result of other study that used rapid ELISA for detection of RABV antibodies in dogs (17) , suggesting that the I-ELISA is suitable for sero-surveillance of RABV in dogs. Further studies using other types of ELISA, such as a blocking ELISA, are needed for sero-surveillance after rabies vaccination in several species, including cattle.
In conclusion, we showed that the I-ELISA results using recombinant RVN protein expressed in a recombinant baculovirus system have a significant correlation with FAVN test results in terms of the detection of RABV antibodies in dog serum samples, indicating that this new I-ELISA assay can be used as a simple and efficient tool for examining a large number of serum samples at once.
